跳至主要内容
临床试验/NCT00836901
NCT00836901已完成1 期

Randomized, 2-Way Crossover, Bioequivalence Study of Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets and AUGMENTIN® 400 Mg-57 mg Chewable Tablets Administered as 1 x 400 Mg-57 mg Chewable Tablet in Healthy Subjects Under Fed Conditions

Teva Pharmaceuticals USA1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2003年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
52
试验地点
1
主要终点
Cmax (Maximum Observed Concentration) - Amoxicillin

研究概览

简要总结

The objective of this study is to compare the rate and extent of absorption of amoxicillin-clavulanic acid 400 mg-57 mg chewable tablets (test) versus Augmentin® (reference) administered as 1 x 400 mg-57 mg chewable tablet under fed conditions.

详细描述

Criteria for Evaluation: FDA Bioequivalence Criteria

Statistical Methods: FDA bioequivalence statistical methods

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Amoxicillin Calvulanic Acid

Experimental

Amoxicillin Clavulanic Acid 400-57 mg Chewable Tablet (test) dosed in first period followed by Augmentin® 40-57 mg Chewable Tablet (reference) dosed in second period

干预措施: amoxicillin-clavulanic acid (Drug)

Augmentin®

Active Comparator

Augmentin® 400-57 mg Chewable Tablet (test) dosed in first period followed by Amoxicillin Clavulanic Acid 400-57 mg Chewable Tablet (reference) dosed in second period

干预措施: Augmentin® (Drug)

结局指标

主要结局

Cmax (Maximum Observed Concentration) - Amoxicillin

时间窗: Blood samples collected over 10 hour period

Bioequivalence based on Cmax

AUC0-inf - [Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated)] - Amoxicillin

时间窗: Blood samples collected over 10 hour period

Bioequivalence based on AUC0-inf

AUC0-t - [Area Under the Concentration-time Curve From Time Zero to Time of Last Non-zero Concentration (Per Participant)] - Amoxicillin

时间窗: Blood samples collected over 10 hour period

Bioequivalence based on AUC0-t

Cmax (Maximum Observed Concentration) - Clavulanic Acid

时间窗: Blood samples were collected over 10 hour period

Bioequivalence based on Cmax

AUC0-inf [Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated)] - Clavunlanic Acid

时间窗: Blood samples collected over 10 hour period

Bioequivalence based on AUC0-inf

AUC0-t [Area Under the Concentration-time Curve From Time Zero to Time of Last Non-zero Concentration (Per Participant) - Clavulanic Acid

时间窗: Blood samples collected over 10 hour period

Bioequivalence based on AUC0-t

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验